BeStock  
Stocks › Biotechnology › ARGX

argenx SE ARGX

US equityMarket cap rank #379Biotechnology
$927.21 +$32.44 (+3.63%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $935.99 +0.95%
Open$894.78
Prev close$894.77
Day range$892.36 – $929.88
Volume379.3K
Market cap$58.31B
P/E (TTM)32.1
Dividend yield–

Earnings

Average move on report day±4.1%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+11.9%
Worst reaction-8.6%

Stock move on the day after each report

-4.4%2023/Q4-0.9%2024/Q1+4.7%2024/Q2+6.3%2024/Q3+0.3%2024/Q4-8.6%2025/Q1+11.9%2025/Q2-0.2%2025/Q3-5.6%2025/Q4-2.5%2026/Q1+8.6%2026/Q2-1.6%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q322 Oct 2026None±9.8%-1.61%Within range
2026/Q223 Jul 2026Pre Market±8.7%+8.56%Within range
2026/Q17 May 2026Pre Market±6.1%-2.51%Within range
2025/Q426 Feb 2026Pre Market±8.1%-5.56%Within range
2025/Q330 Oct 2025None±8.7%-0.20%Within range
2025/Q231 Jul 2025None±8.4%+11.93%Bigger than priced
2025/Q18 May 2025None±6.4%-8.64%Bigger than priced
2024/Q427 Feb 2025None±10.9%+0.27%Within range
2024/Q331 Oct 2024Pre Market±7.7%+6.27%Within range
2024/Q225 Jul 2024None±9.0%+4.73%Within range
2024/Q19 May 2024None±5.4%-0.91%Within range
2023/Q429 Feb 2024None±7.7%-4.45%Within range
2023/Q331 Oct 2023None±10.5%+1.17%Within range
2023/Q227 Jul 2023None±6.4%-2.29%Within range
2023/Q14 May 2023Pre Market±9.6%+0.80%Within range
2022/Q42 Mar 2023None±6.5%-6.48%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2025/FY

By region

  • United States$3.53B 85.1%
  • Rest of the World$342.62M 8.3%
  • Japan$206.84M 5.0%
  • China$67.92M 1.6%

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.72B+52.7% YoY
Operating profit$485.00M+39.8% YoY
Net profit$506.00M+47.1% YoY
Diluted EPS$7.80+50.6% YoY
Free cash flow$267,297.05+113.2% YoY
Operating cash flow$309,579.13

Revenue, last 8 quarters

$741.3MDec '24$790.0MMar '25$949.0MJun '25$1.1BSep '25$1.3BDec '25$1.3BMar '26$1.5BJun '26$1.7BSep '26

Net profit, last 8 quarters

$774.2MDec '24$169.0MMar '25$246.0MJun '25$344.0MSep '25$533.0MDec '25$366.0MMar '26$472.0MJun '26$506.0MSep '26

Profitability & balance sheet

Gross margin90.0%
Operating margin29.9%
Net margin32.2%
Liabilities / assets16.1%
Cash & investments$5.18B
Total debt$36.00M
Net cash (debt)$5.15B

Discussion

No comments yet — be the first to weigh in on ARGX.

Sign in to join the discussion.

Scroll to Top